Training for those who support homeless and people in prison with oral health
Researchers at the University of Dundee, in partnership with NHS Education for Scotland, are leading training for oral health professionals who support people who are homeless or in prison.
Outrun Therapeutics Ltd

Spun out of founder Prof. Satpal Virdee’s lab at the world-renowned MRC Protein Phosphorylation and Ubiquitylation Unit at the University of Dundee, Outrun Therapeutics is a biotech company focused on developing small molecule inhibitors of E3 Ligases to stabilize proteins to treat cancer.
The team specialise in developing small molecule inhibitors that prevent protein degradation by targeting E3 ligases. Their lead program focuses on a small molecule inhibitor for a hard-to-treat solid tumour, aiming to stabilize a crucial tumour suppressor protein.
With an emerging pipeline of E3 ligase inhibitors across oncology and other disease indications, Outrun Therapeutics has deep knowledge of the E3 ligase field and wide-ranging experience in cutting-edge drug discovery technologies to facilitate small molecule discovery and development. The R&D team comprises world-class scientists and is supported internally and externally by experts in multiple scientific and commercial disciplines.
The R&D team at Outrun Therapeutics possesses expertise in:
- Protein production and purification
- Biochemical and cellular biology assay development and execution
- Medicinal chemistry and chemical biology
- Cheminformatics and Computer-Aided Drug Design (CADD)
- Structural biology
- Mass spectrometry
- Preclinical animal models
Prof. Rob Brooker appointed as Executive Director of Science
The James Hutton Institute is very pleased to announce the appointment of Professor Rob Brooker as Executive Director of Science, effective from 1st March.
Catalysing opportunities in Tayside
Image Guided Therapy Research Facility (IGTRF)

The Image Guided Therapy Research Facility (IGTRF) is a distinguished centre dedicated to advancing and supporting all stages of preclinical medical device testing, innovation, and training. In collaboration with the Centre for Anatomy and Human Identification, IGTRF has pioneered the development of a Thiel cadaveric model that enables extracorporeal perfusion of both arterial and venous systems.
This advanced perfusion capability facilitates multimodal imaging and supports a wide range of surgical interventions using a clinically relevant human cadaveric model. As an optimal platform for ‘first-in-human’ testing, the model significantly advances the development of new medical devices, while also providing robust support for regulatory submissions and training in cutting-edge interventional techniques.
As an internationally recognised, multidisciplinary facility, IGTRF offers tailored services to global clients, including industry leaders and academic researchers, enhancing collaboration and innovation at the forefront of medical technology.
The facility boasts current and next generation imaging equipment to support the needs of our clients. These services allow our Medtech clients to gather highly accurate preclinical testing data for design processes and regulatory submissions.
In addition to our advanced imaging equipment, we can offer clients:
Ultrasound
Intravascular ultrasound
- Endoscopic views
- Pressure and Temperature monitor/control
- Post processing of images
- Access to seminar facilities for project discussions and internal live link ups to our interventional imaging rooms
Our team of highly skilled technicians work with clinicians to provide access to a clinically relevant Thiel embalmed human cadaveric model. The knowledgeable team assist with all aspects of a client’s journey.
Tay Health Tech Conference
Women+ In Tech Tayside
Dundee patient first in Europe to get personalised cancer therapy for gastro-oesophageal cancer
A patient from Dundee has become the first patient in Europe on a global trial to be given a personalised cancer therapy (Individualised Neoantigen Therapy - INT) for their type of cancer, using si
Science Futures

Science Futures is an innovative project to support the growth of the science sector across the Tayside region and is being led by Dundee and Angus College (D&AC). It aims to support the growth of the biotech, biomedical, and agritech sectors in the Tay Cities Region. The project has been awarded £1.975 million in funding through the Tay Cities Deal Skills Programme and involves a partnership with University of Dundee, Abertay University, James Hutton Institute, Dundee Science Centre, UHI Perth and Fife College.
The initiative focuses on developing strong partnerships between education and industry to ensure the curriculum is tailored to industry needs by identifying required skills. It seeks to expand course offering within the region with both full-time and short courses available to meet skill demands. The project aims to address skills shortages by creating a skilled workforce aligned with the growth of key sectors, raising awareness of science career pathways for diverse groups, and promoting inclusivity. Additionally, it aims to increase awareness and adoption of Modern Apprentice qualifications by collaborating with industry to boost apprenticeship numbers in the Tayside region during and beyond the project.
N/A
Skills and expertise from all of the partners involved which include Dundee and Angus College, University of Dundee, Abertay University, James Hutton Institute, Dundee Science Centre, UHI Perth and Fife College.